Insights from 2023 SABCS


 

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs. Pembro + Chemo After Induction With Pembro + Chemo for Locally Recurrent Inoperable or Metastatic TNBC"

321 views
December 15, 2023
Comments 0
Login to view comments. Click here to Login